Condition: Squamous Cell Carcinoma of Head and Neck · Sponsor: Universitaire Ziekenhuizen KU Leuven
The study involves head and neck squamous cell carcinomas (HNSCC) of the oral cavity, oropharynx, larynx or hypopharynx with positive nodes on only one side of the neck and no distant metastasis treated by primary (chemo)radiotherapy. The elective node irradiation on the contralateral side is not always mandatory and the dose may be too high. In this study, we evaluate two strategies: the impact of sentinel lymph node mapping to tailor the volumes to irradiate and the dose reduction.
This description comes directly from the study's public registry record.
Jean-François Daisne, MD, PhD · +32-16-34-76-00 · jean-francois.daisne@uzleuven.be
Chris Bruyninckx, BA · +32-16-34-76-00 · chris.bruyninckx@uzleuven.be
Always discuss trial participation with your own doctor first.
| ZOL | Genk, Limburg, Belgium | Recruiting |
| Jessa Ziekenhuis | Hasselt, Limburg, Belgium | Recruiting |
| OLV Aalst | Aalst, Belgium | Recruiting |
| UCL Saint-Luc | Brussels, Belgium | Recruiting |
| Institute Jules Bordet | Brussels, Belgium | Recruiting |
| University Hospital Gent | Ghent, Belgium | Recruiting |
| Universitaire Ziekenhuizen Leuven | Leuven, Belgium | Recruiting |
| AZ Sint-Maarten | Mechelen, Belgium | Recruiting |
| CHU-UCL Namur | Namur, Belgium | Recruiting |
| AZ Turnhout | Turnhout, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04688528